Business Context and Reporting Period
Company: Aethlon Medical, Inc. (AEMD)
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2026
Reporting Period: The filing references financial results for the quarter ended June 30, 2026, disclosed via a press release dated August 13, 2026.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It incorporates the financial results by reference to an attached press release (Exhibit 99.1) but does not contain the specific numerical data within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in the filing text.
- Debt and Liquidity: Not provided in the filing text.
- Key Metrics: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not provide specific data to compare against prior periods. It only indicates that results for the quarter ended June 30, 2026, were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the Company issued a press release regarding its financial results. The content of this commentary is contained in Exhibit 99.1, which is not included in the input text.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 13, 2026) for actual revenue, net loss, and cash position figures.
- Verify the specific details of the "Results of Operations" referenced in Item 2.02, as the text only incorporates them by reference.
- Confirm if the press release contains updated guidance or operational milestones for the remainder of 2026.